Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

AstraZeneca Plans to Help Korean Companies Enter China

publication date: Sep 25, 2024

AstraZeneca Korea has devised a new way to partner with young Korean biohealth companies. It plans to stage the AstraZeneca K-Bio Expressway contest for novel Korean biohealth companies that plan to enter China’s market. The two winners of the contest will receive some cash and guaranteed entry into iCampus, AZ’s open innovation hub in Wuxi, China. Interested companies must submit their proposals by October 11th. Between six and eight companies will be selected to visit the iCampus, and two of them will be chosen for the iCampus program during a pitching session on November 4. More details....

Share this with colleagues:  



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here